• SENSEX 74,294.96
    -19.63 (--0.03%)
  • BANKNIFTY 56,358.70
    302.95 (+0.54%)
  • HDFC Bank
    733.50 1,020.35(%)
  • ITC
    262.20 256.25(%)
  • The Bombay Burmah
    1,531.60 2,135.00(%)
  • Rentomojo
    492.20 480.00(%)
  • Glass Wall Syst.
    304.50 304.50(%)
  • Multi Comm. Exc.
    3,232.00 1,545.65(%)
  • UltraTech Cem.
    10,670.00 10,329.00(%)
  • Adani Total Gas
    674.80 859.70(%)
  • EIH
    320.50 414.90(%)
  • Bajaj Finance
    1,036.10 1,177.60(%)
  • Lords Mark Industries
    89.68 669.70(%)
  • Meesho
    219.80 254.65(%)
  • Syrma SGS Tech.
    1,764.95 1,764.95(%)
  • Aditya Birla Cap
    404.25 430.55(%)
  • Raksan Transformers
    286.65 286.65(%)
  • Atul
    6,195.10 7,198.20(%)
  • Karamtara Engg.
    378.20 378.20(%)
  • TCS
    2,101.00 1,976.00(%)
  • Billionbrains
    195.50 227.00(%)
  • Tata Chemicals
    688.00 581.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alembic Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Alembic Group
  • BSE Code : 40294.0
  • ISIN : INE901L01018
845.75 20 (2.39%)
  • As on 19 Sep 2026 (EOD)

  • Today’s Low

    828.00

  • Today’s High

    860.00

  • Open

    828.00

  • Perv Close

    826.00

  • 52W Low

    635.80

  • 52W High

    998.00

Key Indicators

  • P/E(TTM)

    21.07

  • Mar.Cap (₹Cr.)

    16,624.33

  • Div & Yield %

    1.42

  • Book Value(₹)

    285.67

  • Debt-Equity Ratio

    2.39

  • AGM Date

    18-Sep-2026

  • EPS

    40.14

  • P/E Ratio

    21.07

Financials Ratios

  • Debt-Equity Ratio

    0.13

  • Mar.Cap (₹Cr.)

    16,624.33

  • RONW (%)

    13.40

  • ROCE (%)

    12.93

Score Board

  • Equity (₹ in Cr.)

    39.31

  • BV (₹)

    285.70

  • Sales( ₹ in Cr.)

    6,651.38

  • NP (in Cr.)

    697.08

  • NP Var(%)

    44.0

  • Div%

    600.0

  • CPS (₹)

    51.30

  • EPS (₹)

    35.50

  • Traded Value (₹ in Lakhs)

    16,623.34

  • 52 Week High

    998.00

  • 52 Week Low

    635.80

  • Price BSE

    846.0

  • Price NSE

    846.00

  • Market Capital( in Cr.)

    16,623.34

  • P/C Ratio

    16.50

  • P/E Ratio

    23.90

  • Price Vs.BV

    35.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 6,651.38 6,032.63 5,874.06 5,149.00 5,035.41 5,066.89
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 6,651.38 6,032.63 5,874.06 5,149.00 5,035.41 5,066.89
Other Income 55.90 60.75 504.88 3.55 51.14 83.90
Stock Adjustments 121.15 268.54 52.36 -72.84 -19.85 160.65
Total Income 6,828.43 6,361.92 6,431.30 5,079.71 5,066.70 5,311.44
EXPENDITURE :            
Raw Materials 2,141.95 2,057.31 1,852.71 1,587.29 1,482.36 1,464.67
Power and Fuel Cost 177.44 179.67 173.32 151.19 120.50 118.31
Employee Cost 1,612.90 1,466.57 1,335.91 1,094.82 1,062.30 976.13
Other Manufacturing Expenses 434.18 388.12 327.87 357.21 324.10 344.44
Selling and Administration Expenses 1,299.56 1,269.90 1,191.89 1,173.00 1,088.67 848.55
Miscellaneous Expenses 110.78 38.21 519.76 48.32 28.82 26.07
Employee Benefit Expenses 1,612.90 1,466.57 1,335.91 1,094.82 1,062.30 976.13
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,776.81 5,399.78 5,401.46 4,411.83 4,106.75 3,778.17
Operating Profit 1,051.62 962.14 1,029.84 667.88 959.95 1,533.27
Interest 86.51 76.47 54.47 49.00 17.02 12.98
Gross Profit 965.11 885.67 975.37 618.88 942.93 1,520.29
Depreciation 311.00 277.08 271.14 272.95 284.92 182.55
Profit Before Tax 654.11 608.59 704.23 345.93 658.01 1,337.74
Current Tax 115.14 105.47 37.75 -0.80 114.46 241.20
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -101.45 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 640.42 503.12 666.48 346.73 543.55 1,096.54
Extraordinary Items -56.66 20.18 0.99 0.05 2.81 5.20
Adjusted Net Profit 697.08 482.94 665.49 346.68 540.74 1,091.34
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -76.31 -114.90
P & L Balance brought forward 4,447.81 4,160.91 3,651.68 2,632.89 2,440.83 1,709.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 212.54 216.22 157.25 -672.06 275.19 250.00
P & L Balance carried down 4,875.69 4,447.81 4,160.91 3,651.68 2,632.88 2,440.83
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 600.00 550.00 550.00 400.00 500.00 700.00
Dividend Per Share(Rs) 12.00 11.00 11.00 8.00 10.00 14.00
Earnings Per Share-Unit Curr 32.58 25.60 33.91 17.64 27.65 55.79
Earnings Per Share(Adj)-Unit Curr 32.58 25.60 33.91 17.64 27.65 55.79
Book Value 285.69 264.30 249.75 224.59 269.16 259.57
Book Value(Adj)-Unit Curr 285.69 264.30 249.75 224.59 269.16 259.57

Shareholding Pattern

  • Promoter Group

    69.87%

  • Public Share Holding

    30.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,006,980 1,006,980.00 1,006,980 1,006,980
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,006,980 0.51 1,006,980 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 126,430,609 64.32 126,430,609 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,753,534 4.96 9,753,534 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 150,900 0.08 150,900 7
Others 0 0.00 0 0
Sub Total 136,335,943 69.36 136,335,943 26
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 53,650 0.03 38,550 7
Foreign Bank 3,250 0.00 3,250 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,211,491 4.18 8,211,491 139
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13,549,026 6.89 13,549,026 8
Mutual Funds / UTI 17,168,551 8.73 17,168,551 14
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 560,239 0.29 560,239 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 39,546,207 20.12 39,531,107 179
2] Non Institution
Bodies Corporate 317,923 0.16 309,723 353
Clearing Members 8,390 0.00 8,390 22
Directors of their Relatives 2,398,785 1.22 2,398,785 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,081,715 0.55 1,081,535 2,014
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 890,330 0.45 890,330 4
Individuals holding nominal share capital up to Rs. 1 lakh 12,819,114 6.52 12,006,094 82,638
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 24,263 0.01 24,263 6
Others 1,571,385 0.80 1,571,385 1
Sub Total 19,673,994 10.01 18,851,754 86,590
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 196,563,124 100.00 195,725,784 86,796

Company Background

Alembic Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alembic Pharmaceuticals Ltd
  • BSE Code : 40294.0
  • ISIN : INE901L01018

  • Incorporation Year

    2010

  • Registered Office

    Alembic Road
    , Vadodara,
    Gujarat-390003

  • Telephone

    91-0265-2280550

  • FAX

    91-0265-2282506

  • Chairman

    C R Amin

  • Managing Director

  • Company Secretary

    MANISHA SARAF

  • Auditor

    KKC & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    B-102&103 Shangrila,
    Complex First Floor,Akota
    Mumbai - Vadodara - 390 020

Alembic Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alembic Pharma 845.70 6,707.28 6,651.38 22.65 12.01
Abbott India 27,273.30 7,217.19 6,929.05 35.89 43.78
Astrazeneca Phar 6,751.40 2,304.07 2,275.58 99.50 27.86
Glaxosmi. Pharma 2,851.85 3,932.76 3,790.20 45.56 58.17
Novartis India 2,057.50 393.10 354.33 51.96 15.94
Cipla 1,371.45 20,102.60 18,979.95 36.04 13.88
Bliss GVS Pharma 680.40 773.53 729.81 63.23 12.51
Amrutanjan Healt 493.65 520.13 502.55 26.44 24.16
Fermenta Biotec. 475.75 474.15 450.25 22.21 18.77
Guj. Themis Bio. 427.65 168.25 165.82 114.34 18.05
Ambalal Sarabhai 40.45 19.52 3.94 74.91 6.77